Skip to main content

Regeneron news in 2026: 29 dated events

The latest Regeneron event on this page is dated Oct 30, 2026. grafa.com reported: Regeneron Q3 Revenue Rises 36% to $5.12 Billion.

Public (REGN)Biotechnology Research10,000+ employeesregeneron.comLinkedIn

Get Regeneron's live signals in Claude or ChatGPT, or by API

AskWhat changed at Regeneron this week? Use Autobound signals for regeneron.com.
Dated events
31
Last 90 days
12
Latest
Oct 30, 2026

Source: Autobound Signal API · 94 signals tracked for Regeneron · updated

News · latest 10

Latest Regeneron news

  1. Revenue
    Regeneron Q3 Revenue Rises 36% to $5.12 BillionRegeneron Pharmaceuticals reported third-quarter 2026 revenue of $5.116 billion, up 36% year over year.
  2. Partnership
  3. Office expansion
  4. Investment
    REGN Becomes Final Major Drugmaker To Sign Trump’s Drug Pricing PledgeRegeneron committed more than $9 billion to U.S.-based manufacturing and research-and-development infrastructure investments over the coming years.
  5. New customer
    Sanofi expands its partnership with Regeneron in an $8 billion dealRegeneron will receive $1 billion upon signing and up to an additional $7 billion in future milestone payments from Sanofi as part of an expanded partnership.
  6. In development
  7. Earnings
    Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026Regeneron Pharmaceuticals will report its third quarter 2026 financial and operating results on October 30, 2026.
  8. In development
    Paroxysmal Nocturnal Hemoglobinuria Market Forecast Upto 2036: 5 Emerging Therapies Poised to Accelerate Market GrowthRegeneron Pharmaceuticals is developing Pozelimab + Cemdisiran, a potential therapy for paroxysmal nocturnal hemoglobinuria (PNH).
  9. Launch
    Regeneron Pharmaceuticals (REGN) Wins FDA Approval For Pasatru In Adult FOPRegeneron Pharmaceuticals received FDA approval for its drug Pasatru (garetosmab grts) to treat adults with fibrodysplasia ossificans progressiva (FOP).
  10. Integration

Showing 10 of 31 dated events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Regeneron with the Signal API

One POST /v1/companies/enrich call with regeneron.com returns Regeneron news signals (news), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"regeneron.com","signal_types":["news"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real News records, as a CSV.

Talk to sales

Same industry

Questions about Regeneron news

What is the latest news on Regeneron?
The newest event on this page is dated Oct 30, 2026. grafa.com reported: Regeneron Q3 Revenue Rises 36% to $5.12 Billion. This page lists 31 dated events for Regeneron, each with a source link.
What is going on with Regeneron?
The 10 latest events on this page cover revenue (1), partnership (1), office expansion (1), investment (1), new customer (1), in development (2), earnings (1), launch (1) and integration (1). The newest: Oct 30, 2026: Regeneron Q3 Revenue Rises 36% to $5.12 Billion (grafa.com).

Page updated , the date of the newest row on this page.

Source. News articles about the company, one source link per event.

Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.

Data as of .

How this data is built →Get it from the Signal API →